Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Credit Suisse Upgrades Schroders, Cuts Hargreaves

Tue, 04th Nov 2014 09:49

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
BERENBERG CUTS NEXT PRICE TARGET TO 7775 (8075) PENCE - 'BUY'
----------
TRADERS: MORGAN STANLEY RAISES HSBC PRICE TARGET TO 590 (560) PENCE
----------
TRADERS: MORGAN STANLEY CUTS PRICE TARGET STANDARD CHARTERED TO 850 (1130) PENCE
----------
UBS RAISES HSBC PRICE TARGET TO 725 (715) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES SCHRODERS TO 'OUTPERFORM' ('NEUTRAL')
----------
CREDIT SUISSE CUTS HARGREAVES LANSDOWN TO 'NEUTRAL' ('OUTPERFORM')
----------
CREDIT SUISSE CUTS AGGREKO PRICE TARGET TO 1240 (1471) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS NATIONAL GRID TO 'UNDERPERFORM' ('NEUTRAL') - TARGET 830 PENCE
----------
EXANE BNP RAISES RBS PRICE TARGET TO 400 (375) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES BARCLAYS PRICE TARGET TO 315 (300) PENCE - 'BUY'
----------
CITIGROUP RAISES RBS PRICE TARGET TO 345 (330) PENCE - 'SELL'
----------
UBS RAISES SHIRE TO 'BUY' ('NEUTRAL') - TARGET 5000 (5390) PENCE
----------
TRADERS: HSBC CUTS EXPERIAN TO 'NEUTRAL' ('OVERWEIGHT')
----------
TRADERS: NUMIS RAISES WEIR GROUP TO 'ADD' ('HOLD')
----------
DAVY INITIATES RIO TINTO WITH 'UNDERPERFORM' - TARGET 2575 PENCE
----------
FTSE 250
----------
TRADERS: JEFFERIES CUTS REGUS PLC TO 'HOLD'
----------
UBS RAISES HISCOX TO 'BUY' ('NEUTRAL') - TARGET 730 (700) PENCE
----------
TRADERS: UBS CUTS AMLIN TO 'NEUTRAL' ('BUY')
----------
BERENBERG CUTS SUPERGROUP PRICE TARGET TO 1160 (1480) PENCE - 'BUY'
----------
UBS CUTS UBM PRICE TARGET TO 700 (760) PENCE - 'BUY'
----------
CREDIT SUISSE RESUMES MAN GROUP WITH 'OUTPERFORM' - TARGET 138 PENCE
----------
TRADERS: HSBC RAISES MAN GROUP TO 'OVERWEIGHT' ('NEUTRAL')
----------
HSBC RAISES MAN GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 150 (132) PENCE
----------
CREDIT SUISSE CUTS ASHMORE GROUP TO 'UNDERPERFORM' ('NEUTRAL')
----------
CREDIT SUISSE RAISES JUPITER FUND TO 'NEUTRAL' ('UNDERPERFORM')
----------
GOLDMAN CUTS ELEMENTIS PRICE TARGET TO 315 (330) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES BETFAIR PRICE TARGET TO 1348 (1290) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS UBM PRICE TARGET TO 618 (635) PENCE - 'OVERWEIGHT'
----------
BERENBERG CUTS UBM PRICE TARGET TO 540 (580) PENCE - 'HOLD'
----------
UBS CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 620 (640) PENCE - 'NEUTRAL'
----------
UBS RAISES CATLIN GROUP PRICE TARGET TO 525 (520) PENCE - 'NEUTRAL'
----------
UBS RAISES BRIT PLC PRICE TARGET TO 255 (245) PENCE - 'BUY'
----------
TRADERS: NUMIS RAISES JARDINE LLOYD THOMPSON TO 'ADD' ('HOLD')
----------
MAIN MARKET AND AIM
----------
TRADERS: INVESTEC RESUMES CONSORT MEDICAL WITH 'BUY' - TARGET 986 PENCE
----------
TRADERS: LIBERUM INITIATES E2V TECHNOLOGIES WITH 'BUY' - TARGET 200 PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2017 08:10

Consort Medical splutters as BAT stubs out Voke programme

(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut

Read more
6 Dec 2016 08:18

Consort Medical posts good growth in first half

(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%

Read more
25 Nov 2016 09:07

Consort Medical appoints new CFO

(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive

Read more
27 Oct 2016 07:45

Consort Medical Welcomes Cimzia Autoclicks Launch On NHS

Read more
14 Oct 2016 12:23

Consort Medical's Bespak inks new agreement

(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat

Read more
19 Sep 2016 09:07

Consort Notes European Nod For Bespak Technology-Using Product

Read more
7 Sep 2016 08:43

Consort Medical signs agreement with AstraZeneca

(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be

Read more
7 Sep 2016 07:03

Consort Medical Sees Little Brexit Impact; Signs Deal With AstraZeneca

Read more
23 Jun 2016 15:19

Director dealings: Derwent London CEO sells just ahead of Brexit vote

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref

Read more
17 Jun 2016 09:29

Numis places Consort Medical 'under review'

(ShareCast News) - Consort Medical's shares were put 'under review' by Numis after the company reported its full year results. The pharmaceutical device frim on Thursday reported full year earnings before interest and tax rose 47.6% to £37m as revenues gained 49.8% to £276.9m, driven by a strong per

Read more
16 Jun 2016 14:52

Consort Medical's annual revenues rise as a product launch is delayed

(ShareCast News) - Consort Medical, a pharmaceutical device company, revealed higher full year profits on Thursday due to organic growth and an acquisition. Revenues rose 49.8% to £276.9m from £184.8m the previous financial year. Bespak, the company's drug device manufacturing subsidiary, continued

Read more
16 Jun 2016 07:37

Consort Medical Profit Doubles As Progress Made On DEV610 Programme

Read more
9 Jun 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
22 Feb 2016 16:51

Consort Medical agrees partnership and invests in Precision Ocular

(ShareCast News) - Consort Medical has made a £3.3m equity investment for a 13.7% stake in retinal therapeutics specialist Precision Ocular and agreed a development and manufacturing partnership. London-based Precision Ocular has developed retinal treatments that are designed to access specific sma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.